MEDIA

Nanexa invites to investor meeting on October 9th in Uppsala

28 September, 2023
- Press Release
Download attachment

Nanexa AB invites investors and analysts to the company’s premises at Uppsala Business Park on Monday, October 9th, from 10:00 AM to 13:00 PM. Chairman Göran Ando, CEO David Westberg and others from the management team will present the company, the rationale and objectives for the announced rights issue, and future plans.

The presentation will be given in Swedish and participants will have the opportunity to ask questions.

Date: Monday, October 9th.

Time: 10:00 AM to 1:00 PM; a light lunch will be served starting at 12:00 PM.

Location: Uppsala Business Park, Rapsgatan 7, Uppsala.

Please register via email to maria.medeen@nanexa.se no later than October 5th.

For additional information, please contact:

David Westberg – CEO, Nanexa AB (publ) 
Phone: +46 70 942 83 03
Email: david.westberg@nanexa.se
www.nanexa.com
Erik Penser Bank is the company’s Certified Adviser and can be reached on +46 8 463 83 00, email: certifiedadviser@penser.se

About Nanexa AB (publ)

Nanexa is a pharmaceutical company developing injectable drug products based on the proprietary and innovative drug delivery system PharmaShell® – the high drug load delivery system enabling the next generation long-acting injectables through atomic layer precision. Nanexa develops its own products and also has collaboration agreements with several pharma companies, among others Novo Nordisk and AstraZeneca.

Nanexa’s share is listed on Nasdaq First North Growth Market in Stockholm (NANEXA).

Attachments

Nanexa invites to investor meeting on October 9th in Uppsala